Alterity Therapeutics Ltd.ASX: ATH

EU Regulatory Guidance for ATH434 Phase 2 Clinical Trial

Jun 23, 2021 at 5:17 AM UTC · Issued by Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd has released a press release.

View Attachment